“…One drawback of serological assays with whole parasites is the existence of cross-reactivity with other pathogens, including Trypanosoma cruzi, mycobacteria, malaria parasites, or amoebae, which are coendemic with Leishmania in many parts of the world (7,51). The performance of serodiagnostic assays could be improved by using purified or recombinant leishmanial antigens, such as gp63 (40,41,56), Hsp70 (30,48), p94 (53), gp70 and p72 (24), p32 (61), rK39 (2,11), r gene B protein (rGBP) (15,31), H2A and H2B (31,57,58,59), rLACK (31), and the promastigote surface antigen 2 (rPSA-2) (18,31,37), or synthetic peptides (14,48) and antigens from promastigote-conditioned media (33).…”